Literature DB >> 14677199

Severe Raynaud's phenomenon with yohimbine therapy for erectile dysfunction.

Sindhu Johnson1, John Iazzetta, Catharine Dewar.   

Abstract

Yohimbine is a selective alpha-2 adrenergic antagonist that has been used in the pharmacologic management of erectile dysfunction (ED). We describe a patient with CREST syndrome (calcinosis, Raynaud's phenomenon, esophageal dysfunction, sclerodactyly, and telangiectasia) who paradoxically experienced worsening of Raynaud's phenomenon when using yohimbine for ED.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14677199

Source DB:  PubMed          Journal:  J Rheumatol        ISSN： 0315-162X            Impact factor:   4.666


  2 in total

Review 1.  Drug-induced Raynaud's phenomenon: beyond β-adrenoceptor blockers.

Authors:  Charles Khouri; Sophie Blaise; Patrick Carpentier; Céline Villier; Jean-Luc Cracowski; Matthieu Roustit
Journal:  Br J Clin Pharmacol       Date:  2016-04-07       Impact factor: 4.335

2.  Reverse takotsubo cardiomyopathy with use of male enhancers.

Authors:  Carlos E Rodriguez-Castro; Fatima Saifuddin; Mateo Porres-Aguilar; Sarmad Said; David Gough; Tariq Siddiqui; Debabrata Mukherjee; Aamer Abbas
Journal:  Proc (Bayl Univ Med Cent)       Date:  2015-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.